SILVERARC CAPITAL MANAGEMENT, LLC
Top Portfolio Positions
54 positions ·
$585,561,637 total
· as of Dec 31, 2025
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
1,245,254 | $44,231,422 | 7.55% |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
1,738,821 | $40,723,187 | 6.95% |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
2,427,118 | $39,197,955 | 6.69% |
| CELC |
Celcuity Inc.
Healthcare
|
375,132 | $37,415,665 | 6.39% |
| NUVL |
Nuvalent, Inc.
Healthcare
|
311,430 | $31,326,743 | 5.35% |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
750,136 | $30,913,104 | 5.28% |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
1,023,122 | $28,606,491 | 4.89% |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
82,465 | $24,305,734 | 4.15% |
| IMNM |
Immunome Inc.
Healthcare
|
1,126,210 | $24,190,990 | 4.13% |
| GUTS |
Fractyl Health, Inc.
Healthcare
|
9,840,041 | $21,648,090 | 3.70% |
Portfolio Trend
Holdings in PCVX
Export CSVShares Held
Position Value (USD)
7 of 7 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $6,865,032 | 148,787 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $11,322,490 | 314,339 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $9,356,247 | 287,796 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $3,338,905 | 40,788 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,913,335 | 60,500 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $188,775 | 2,500 | Shares | Sole | 2024-08-14 | |
| 2022-12-31 | $3,986,323 | 83,135 | Shares | Sole | 2023-02-14 | |
| No quarters match your search. | ||||||